Regeneron Pharmaceuticals (REGN) Q2 2020 Earnings

5MayConfirmed
Q3 2019
Q4 2019
Q1 2020
Q2 2020
5.5
6.17
6.83
7.5

Details

Expected EPS
6
Actual EPS
6.6
Surprise EPS
0.6
Surprise Percent
+10%

Description

Regeneron Pharmaceuticals (REGN) has reported earnings of 6.6 per share for Q2 2020.

0 Comments

Share your thoughts